231 related articles for article (PubMed ID: 37298415)
1. The Coming of Age of the P2X7 Receptor in Diagnostic Medicine.
Di Virgilio F; Vultaggio-Poma V; Falzoni S; Giuliani AL
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298415
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
Schmidt S; Isaak A; Junker A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674884
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
5. Characterization of
Territo PR; Meyer JA; Peters JS; Riley AA; McCarthy BP; Gao M; Wang M; Green MA; Zheng QH; Hutchins GD
J Nucl Med; 2017 Mar; 58(3):458-465. PubMed ID: 27765863
[TBL] [Abstract][Full Text] [Related]
6. Radioligands targeting purinergic P2X7 receptor.
Zheng QH
Bioorg Med Chem Lett; 2020 Jun; 30(12):127169. PubMed ID: 32273217
[TBL] [Abstract][Full Text] [Related]
7. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.
Arulkumaran N; Unwin RJ; Tam FW
Expert Opin Investig Drugs; 2011 Jul; 20(7):897-915. PubMed ID: 21510825
[TBL] [Abstract][Full Text] [Related]
8. [
Van Weehaeghe D; Koole M; Schmidt ME; Deman S; Jacobs AH; Souche E; Serdons K; Sunaert S; Bormans G; Vandenberghe W; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2051-2064. PubMed ID: 31243495
[TBL] [Abstract][Full Text] [Related]
9. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
[TBL] [Abstract][Full Text] [Related]
12. Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain.
Alves LA; Bezerra RJ; Faria RX; Ferreira LG; da Silva Frutuoso V
Molecules; 2013 Sep; 18(9):10953-72. PubMed ID: 24013409
[TBL] [Abstract][Full Text] [Related]
13. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
14. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
15. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
16. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
17. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
18. Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine.
Gubert C; Fries GR; Pfaffenseller B; Ferrari P; Coutinho-Silva R; Morrone FB; Kapczinski F; Battastini AMO
Mol Neurobiol; 2016 Jan; 53(1):611-620. PubMed ID: 25502294
[TBL] [Abstract][Full Text] [Related]
19. Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe Epilepsy.
Conte G; Menéndez-Méndez A; Bauer S; El-Naggar H; Alves M; Nicke A; Delanty N; Rosenow F; Henshall DC; Engel T
Cells; 2021 Sep; 10(9):. PubMed ID: 34572093
[TBL] [Abstract][Full Text] [Related]
20. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
Humphreys BD; Virginio C; Surprenant A; Rice J; Dubyak GR
Mol Pharmacol; 1998 Jul; 54(1):22-32. PubMed ID: 9658186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]